A sequential injection fluorometric procedure for the determination of procaine in human blood and pharmaceuticals
- 106 Downloads
An automated procedure for the assay of procaine hydrochloride in human blood and pharmaceuticals was developed using a sequential injection (SI) technique with fluorometric detection and fluorescamine as the fluorescence probe. A few microliters of fluorescamine and procaine hydrochloride solutions were used in the SI system leading to the formation of a derivative, which was then excited by a 400-nm LED and whose emitted fluorescence was monitored at a wavelength of 494 nm. A linear calibration graph was obtained with 10–200 ng mL−1 (procaine) by loading 10.0 μL of sample solution and 5.0 μL of fluorescamine solution (both 0.125 % m/v). A detection limit of 2.6 ng mL−1, defined as 3 times the blank standard deviation (3σ), was achieved along with a sampling frequency of 25 h−1 and a precision of 2.1 % RSD at the 50.0 ng mL−1 level. Procaine contents in injection solutions from various pharmaceutical manufactures were analyzed and reasonable agreement was achieved between the values obtained by using the present procedure and the documented spectrophotometry, and both were coincident with the nominal concentrations. In addition, the degradation of procaine in human blood was investigated. A fast degradation of procaine in human blood was observed for the first 30 min, while afterwards the degradation was retarded.
KeywordsSequential injection Fluorometry Procaine degradation Fluorecamine
The authors are indebted to the financial support from the National Natural Science Foundation of China (NSFC-20375007, 20575010, NSFC-RFBR joint program), the key project for scientific research from the Ministry of Education (105056), the Natural Science Foundation of Liaoning Province, China (20042011, 20051013), and the SRFDP program (20050145026).
- 1.The United States Pharmacopoeia Convention Inc., Rockville, MD, 23rd revision, vol II, 1995 p 1298Google Scholar
- 2.The British Pharmacopoeia, British Pharmacopoeia Commission, London, HMSO, vol I, 1993, p 544Google Scholar
- 3.Pharmacopoeia Commission, Ministry of Health, The Chinese Pharmacopoeia, vol 2, 5th edn, PRC Chemical Industry Press, Beijing, 1995, p 711Google Scholar
- 4.Murillo Pulgarin JA, Alanon Molina A, Rodriguez Flores J (1992) Anal Lett 25(7):1275–1288Google Scholar
- 16.Wang AJ, Fan J, Feng SL, Cui FL (2005) Spectrosc Spec Anal 25(3):432–435Google Scholar
- 18.Lin DJ, Li LD (1997) Spectrosc Spec Anal 17(3):10–15Google Scholar